Sfoglia per Titolo
J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1275-9. Epub 2010 Jul 18. Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury.
2010-01-01 Fabbri, A; Servadei, F; Marchesini, G; Stein, Sc; Vandelli, A
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy
2019-01-01 Gremese, Elisa; Alivernini, Stefano; Tolusso, Barbara; Zeidler, Martin P; Ferraccioli, Gianfranco
JAK inhibition in inflammatory bowel disease
2017-01-01 Olivera, P; Danese, S; Peyrin-Biroulet, L
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2016-01-01 Danese, S; Grisham, M; Hodge, J; Telliez, Jb
JAK inhibitors: Novel developments in management of ulcerative colitis
2018-01-01 Fiorino, G; D'Amico, F; Italia, A; Gilardi, D; Furfaro, F; Danese, S
JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis
2020-01-01 D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?
2019-01-01 Danese, S; Argollo, M; Le Berre, C; Peyrin-Biroulet, L
JAK selectivity: more precision less troubles
2020-01-01 Roda, Giulia; Dal Buono, Arianna; Argollo, Marjorie; Danese, Silvio
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease
2020-01-01 Salas, A; Hernandez-Rocha, C; Duijvestein, M; Faubion, W; Mcgovern, D; Vermeire, S; Vetrano, S; Vande Casteele, N
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Cancer. 2006 Nov 1;107(9):2206-11. PubMed PMID: 16998940.
2006-01-01 Rumi, E; Passamonti, F; Pietra, D; Della Porta, M; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M
JAK2 mutation and atypical chronic myeloid leukemia
2009-01-01 Campiotti, Leonardo; Uccella, Silvia; Appio, Lorena; Pallotti, Francesco; LA ROSA, Stefano; Capella, CARLO RENATO; Venco, Achille
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib
2018-01-01 Bonometti, A.; Bagnoli, F.; Fanoni, D.; Venegoni, L.; Corti, L.; Bianchi, P.; Elli, E. M.; Isimbaldi, G.; L'Imperio, V.; Nazzaro, G.; Passoni, E.; Berti, E.
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials
2018-01-01 D'Amico, F; Fiorino, G; Furfaro, F; Allocca, M; Danese, S
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature
2021-01-01 Novelli, Lucia; Motta, Francesca; De Santis, Maria; Ansari, Aftab A; Gershwin, M Eric; Selmi, Carlo
The Janus-faced role of TRPM2-S in retroperitoneal liposarcoma via increasing ROS levels
2022-01-01 Li, Xiangji; Bu, Fanqin; Ma, Shixiang; Cananzi, Ferdinando; Zhao, Yu; Xiao, Mengmeng; Min, Li; Luo, Chenghua
Japanese approach to hepatocellular carcinoma
2001-01-01 Torzilli, G.
JAUNDICE RECURRENCE AFTER TRANSPAPILLARY BILIARY METAL STENT PLACEMENT SUCCESSFULLY TREATED BY EUS GUIDED CHOLEDOCHODUODENOSTOMY WITH LUMEN APPOSING METAL STENT
2019-01-01 Fugazza, A; Anderloni, A; Pellegatta, G; Troncone, E; Attardo, S; Cappello, A; Maroni, L; Ormando, Vm; Palma, R; Carrara, S; Di Leo, M; Galtieri, Pa; Ferrara, E; Maselli, R; Repici, A
Jetrea: a door opening to the future
2015-01-01 Romano, Mario R.
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
2019-01-01 Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M
John Rhea Barton: the birth of osteotomy
2013-01-01 Di Matteo, B; Tarabella, V; Filardo, Giuseppe; Viganò, A; Tomba, P; Marcacci, Maurilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1275-9. Epub 2010 Jul 18. Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury. | 1-gen-2010 | Fabbri, A; Servadei, F; Marchesini, G; Stein, Sc; Vandelli, A | |
| JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy | 1-gen-2019 | Gremese, Elisa; Alivernini, Stefano; Tolusso, Barbara; Zeidler, Martin P; Ferraccioli, Gianfranco | |
| JAK inhibition in inflammatory bowel disease | 1-gen-2017 | Olivera, P; Danese, S; Peyrin-Biroulet, L | |
| JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines | 1-gen-2016 | Danese, S; Grisham, M; Hodge, J; Telliez, Jb | |
| JAK inhibitors: Novel developments in management of ulcerative colitis | 1-gen-2018 | Fiorino, G; D'Amico, F; Italia, A; Gilardi, D; Furfaro, F; Danese, S | |
| JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis | 1-gen-2020 | D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? | 1-gen-2019 | Danese, S; Argollo, M; Le Berre, C; Peyrin-Biroulet, L | |
| JAK selectivity: more precision less troubles | 1-gen-2020 | Roda, Giulia; Dal Buono, Arianna; Argollo, Marjorie; Danese, Silvio | |
| JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease | 1-gen-2020 | Salas, A; Hernandez-Rocha, C; Duijvestein, M; Faubion, W; Mcgovern, D; Vermeire, S; Vetrano, S; Vande Casteele, N | |
| JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Cancer. 2006 Nov 1;107(9):2206-11. PubMed PMID: 16998940. | 1-gen-2006 | Rumi, E; Passamonti, F; Pietra, D; Della Porta, M; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M | |
| JAK2 mutation and atypical chronic myeloid leukemia | 1-gen-2009 | Campiotti, Leonardo; Uccella, Silvia; Appio, Lorena; Pallotti, Francesco; LA ROSA, Stefano; Capella, CARLO RENATO; Venco, Achille | |
| JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib | 1-gen-2018 | Bonometti, A.; Bagnoli, F.; Fanoni, D.; Venegoni, L.; Corti, L.; Bianchi, P.; Elli, E. M.; Isimbaldi, G.; L'Imperio, V.; Nazzaro, G.; Passoni, E.; Berti, E. | |
| Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials | 1-gen-2018 | D'Amico, F; Fiorino, G; Furfaro, F; Allocca, M; Danese, S | |
| The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature | 1-gen-2021 | Novelli, Lucia; Motta, Francesca; De Santis, Maria; Ansari, Aftab A; Gershwin, M Eric; Selmi, Carlo | |
| The Janus-faced role of TRPM2-S in retroperitoneal liposarcoma via increasing ROS levels | 1-gen-2022 | Li, Xiangji; Bu, Fanqin; Ma, Shixiang; Cananzi, Ferdinando; Zhao, Yu; Xiao, Mengmeng; Min, Li; Luo, Chenghua | |
| Japanese approach to hepatocellular carcinoma | 1-gen-2001 | Torzilli, G. | |
| JAUNDICE RECURRENCE AFTER TRANSPAPILLARY BILIARY METAL STENT PLACEMENT SUCCESSFULLY TREATED BY EUS GUIDED CHOLEDOCHODUODENOSTOMY WITH LUMEN APPOSING METAL STENT | 1-gen-2019 | Fugazza, A; Anderloni, A; Pellegatta, G; Troncone, E; Attardo, S; Cappello, A; Maroni, L; Ormando, Vm; Palma, R; Carrara, S; Di Leo, M; Galtieri, Pa; Ferrara, E; Maselli, R; Repici, A | |
| Jetrea: a door opening to the future | 1-gen-2015 | Romano, Mario R. | |
| JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1 | 1-gen-2019 | Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M | |
| John Rhea Barton: the birth of osteotomy | 1-gen-2013 | Di Matteo, B; Tarabella, V; Filardo, Giuseppe; Viganò, A; Tomba, P; Marcacci, Maurilio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile